Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Authors: Randi Hagerman, Sebastien Jacquemont, Elizabeth Berry-Kravis, Vincent Des Portes, Andrew Stanfield, Barbara Koumaras, Gerd Rosenkranz, Alessandra Murgia, Christian Wolf, George Apostol, Florian von Raison

Source: Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)

Subject Terms: Mavoglurant, Core Studies, Fragile X Mental Retardation Protein (FMRP), Repetitive Behavior Scale-Revised (RBS-R), Extension Study Baseline, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/b0c86247e00a4aa7a01f18f018f9be46